Coronavirus Update: Regeneron Races Into Phase III Trial Of Antibodies To Block Coronavirus Infection
Plus Updates On Mylan, Sinovac, Zydus Cadila
Regeneron and NIAID kick off a Phase III prevention trial for antibody cocktail REGN-COV2.

Regeneron and NIAID kick off a Phase III prevention trial for antibody cocktail REGN-COV2.